A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors

COMPLETED

Columbia University Medical Center, New York

RECRUITING

Weil Cornell University, New York

COMPLETED

Roswell Park Comprehensive Cancer Center, Buffalo

RECRUITING

University of Pennsylvania, Philadelphia

RECRUITING

Sarah Cannon Research Institute - Thomas Jefferson University, Philadelphia

RECRUITING

NEXT Oncology, Fairfax

RECRUITING

Emory University, Atlanta

WITHDRAWN

Orlando Health, Orlando

RECRUITING

Sarah Cannon Research Institute, Nashville

COMPLETED

Indiana University, Indianapolis

RECRUITING

Karmanos Cancer Institute, Detroit

RECRUITING

University of Wisconsin, Madison

RECRUITING

OSF St Francis Medical Center, Peoria

RECRUITING

Sarah Cannon Research Institute - Oklahoma University, Oklahoma City

RECRUITING

NEXT Oncology, Irving

RECRUITING

MD Anderson, Houston

RECRUITING

NEXT Oncology, San Antonio

RECRUITING

Sarah Cannon Research Institute, Denver

RECRUITING

START Mountain Region, West Valley City

RECRUITING

HonorHealth Research Institute, Phoenix

RECRUITING

Comprehensive Cancer Centers of Nevada, Las Vegas

RECRUITING

The Angeles Clinic, Los Angeles

RECRUITING

Hoag Memorial Hospital, Newport Beach

WITHDRAWN

California Pacific Medical Center, San Francisco

RECRUITING

Swedish Cancer Institute, Seattle

RECRUITING

Yale University, New Haven

RECRUITING

Dana Faber Cancer Institute, Boston